EdgeRock Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $399K | Buy |
2,154
+136
| +7% | +$25.2K | 0.13% | 69 |
|
|
2025
Q1 | $423K | Buy |
2,018
+113
| +6% | +$23.7K | 0.3% | 44 |
|
|
2024
Q4 | $339K | Buy |
1,905
+101
| +6% | +$18K | 0.22% | 52 |
|
|
2024
Q3 | $356K | Buy |
1,804
+88
| +5% | +$17.4K | 0.25% | 49 |
|
|
2024
Q2 | $294K | Buy |
1,716
+304
| +22% | +$52.2K | 0.23% | 43 |
|
|
2024
Q1 | $257K | Buy |
1,412
+47
| +3% | +$8.55K | 0.2% | 50 |
|
|
2023
Q4 | $232K | Buy |
+1,365
| New | +$232K | 0.17% | 53 |
|
|
2022
Q4 | – | Sell |
-866
| Closed | -$116K | – | 61 |
|
|
2022
Q3 | $116K | Buy |
+866
| New | +$116K | 0.07% | 73 |
|